[{"Assets_0_Q1_USD":276745000.0,"EarningsPerShareBasic_1_Q1_USD":0.29,"EarningsPerShareDiluted_1_Q1_USD":0.27,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":49914000.0,"PaymentsOfDividendsCommonStock_1_Q1_USD":38000.0,"StockholdersEquity_0_Q1_USD":-213558000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":113566000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":100604000.0,"Ticker":"INVA","CIK":"1080014","name":"INNOVIVA, INC.","OfficialName":"Innoviva Inc. Common Stock","form":"10-Q","period":"20180331","fy":"2018.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"1257937389.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20180504"}]